What is the market valuation of continuous glucose monitoring?

The market size of continuous glucose monitoring in 2027 is calculated to be USD 15.9 Billion.

What is the projected value of the continuous glucose monitoring industry by 2036?

Continuous Glucose Monitoring Market size was valued at USD 13.87 Billion in 2026 and is projected to grow at 16.95% CAGR from 2027 to 2036, reaching USD 66.39 Billion by 2036.

How is diabetes management transformation accelerating continuous glucose monitoring adoption?

Rising demand for convenient and personalized glucose management is driving adoption of continuous monitoring solutions that provide real-time insights and support better treatment decisions for users and healthcare providers.

How is AI integration enhancing the value of continuous glucose monitoring systems?

AI-enabled analytics are improving glucose trend interpretation, predictive capabilities, and personalized insights, allowing monitoring systems to deliver more actionable information from continuously collected data.

Why are sensors the leading component in continuous glucose monitoring systems?

Sensors accounted for 53.53% of the market in 2026 and remain central due to real-time glucose measurement, improved accuracy, longer wear duration, and enhanced patient comfort.

What is driving adoption of continuous glucose monitoring in home care settings?

Home care settings held a 79.38% share in 2026 as patients increasingly prefer convenient self-monitoring, remote care support, and connected digital health solutions.

What supports North America's leadership in continuous glucose monitoring?

North America accounted for 49.93% in 2026, reflecting strong adoption of advanced diabetes technologies, developed healthcare infrastructure, and integration with digital health platforms.

Why is Asia Pacific expected to see the fastest continuous glucose monitoring growth?

Asia Pacific is expanding fastest as diabetes prevalence rises and healthcare access, medical technology infrastructure, specialized care, and awareness of advanced monitoring improve.

Which companies dominate the continuous glucose monitoring landscape?

Major players in the continuous glucose monitoring market include Abbott Laboratories (United States), Dexcom, Inc. (United States), Medtronic plc (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), Senseonics Holdings, Inc. (United States), Sinocare Inc. (China), A. Menarini Diagnostics S.r.l. (Italy), i-SENS, Inc. (South Korea), Medtrum Technologies Inc. (China), Zhejiang POCTech Co., Ltd. (China)